UK NSC updates info on how commercial screening tests differ from NHS programmes
We have published updated information on paid-for commercial screening tests and how they differ from quality-assured end-to-end NHS screening programmes
Search results for about
UK NSC publishes new declaration of interests guidance
The UK NSC has updated its guidance and processes for individuals working with the committee to declare any interests that may conflict, or be perceived to conflict, with that work.
UK NSC expands its digital reach during 2023
There were nearly 290,000 separate visits to the UK NSC's 3 online platforms during 2023, reflecting the committee's ongoing commitment to continually improve its stakeholder engagement.
Minutes published of UK NSC’s November 2023 meeting
The UK NSC has endorsed the use of digital pathology as an alternative option to light microscopy for the review of cancer screening histopathology slides.
Three chapters added to UK NSC screening manual
Three chapters added to UK NSC screening in healthcare manual which gives an overview of best practice for implementing health screening programmes anywhere in the world.
Survey's positive feedback for UK NSC blog and web pages
UK NSC survey results give big thumbs-up to blog and constructive feedback on web pages.
Seminar explains process of planning and running an in-service evaluation
Nearly 100 people logged on to the second UK NSC web-based seminar, which focused on planning and implementing an in-service evaluation.
UK NSC welcomes major new prostate cancer screening research
The UK NSC is very excited by the news, announced on International Men’s Day, of a major new prostate cancer screening trial backed by £42 million of funding from Prostate Cancer UK and the government.
Tell us what you think of the UK NSC’s web pages
Please complete a short survey to help us make sure the UK NSC web pages are fit for purpose and meet the needs of all our stakeholders.
Progress update on UK NSC’s recommendation to screen for tyrosinaemia
Oversight group gets to work in following up UK NSC’s recommendation for the implementation of newborn screening for Hereditary Tyrosinaemia Type 1.